Just one-third of medicines for rare diseases licensed for patients in Europe are available in Ireland, according to new figures released on Rare Disease Day by the Irish Pharmaceutical Healthcare Association (IPHA), the representative body for the research-based pharmaceutical industry.
According to the figures, just 29% of all available orphan medicines licensed by the European Medicines Agency for use in patients in 27 European countries were available to patients here.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
